Medical marijuana advocates want drug reclassified

by Frederic J. Frommer

(AP)—A federal appeals court in Washington is considering whether marijuana should be reclassified from its current status as a dangerous drug with no accepted medical use.

Last year, the rejected a petition by medical marijuana advocates to change the classification—thus keeping marijuana in the same category as drugs such as heroin. The DEA concluded that there wasn't a consensus of medical opinion on using marijuana for medical purposes.

Advocates want the U.S. for the District of Columbia Circuit to force the agency to hold a hearing and conduct findings based on the scientific record.

A lawyer for the advocates told the judges on Tuesday that the DEA has misapplied the law. A government lawyer urged the court to deny the request.

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

US governors seek federal marijuana clearance

Dec 01, 2011

A pair of US governors have filed a petition asking the US federal government to allow wider use of medical marijuana by authorizing doctors to prescribe it and pharmacies to provide it.

Conservative county OKs medical pot

Jul 18, 2007

Conservative Orange County, Calif., will license the use of medical marijuana and issue ID cards to patients entitled to use it.

Recommended for you

Supermaterial gives rejected drugs a new chance

10 hours ago

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments